J&J Unit Wants ASC To Turn Over Ditropan Docs

Law360, New York (September 6, 2007, 12:00 AM EDT) -- Johnson & Johnson subsidiary Alza Corp. is asking a court to force American Sales Co. to turn over documents and discovery it argues are central to the plaintiffs' claims that the company maintained a monopoly over blockbuster incontinence drug Ditropan XL by preventing copycat versions from reaching the marketplace.

In court documents filed Thursday in the U.S. District Court for the Northern District of California, Alza accused direct purchaser ASC of bringing a number of issues into play in the litigation while at the same time...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.